EDRE
PPH icon

Edmond de Rothschild (Europe)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-21,770
Closed -$1.37M – 271
2015
Q3 		$1.37M Sell
21,770
-1,500
-6% -$105K 0.64% 44
2015
Q2 		$1.65M Buy
+23,270
New +$1.68M 0.53% 50

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Edmond de Rothschild (Europe)'s PPH Position: Q4 2015 in Review

Edmond de Rothschild (Europe) sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2015, closing a stake of 21,770 shares — an estimated $1.37M sold.

Edmond de Rothschild (Europe) first reported a position in PPH in Q2 2015 and held it in 2 quarters. The position peaked at $1.65M in Q2 2015. 59 funds tracked by Wall St. Rank hold PPH as of Q4 2015.

  • Edmond de Rothschild (Europe) reported no remaining VanEck Pharmaceutical ETF position as of Q4 2015 after selling out during the quarter.
  • Edmond de Rothschild (Europe) sold 21,770 VanEck Pharmaceutical ETF shares in Q4 2015, an estimated $1.37M.
  • Edmond de Rothschild (Europe) first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and held it in 2 quarters.
  • Edmond de Rothschild (Europe)'s VanEck Pharmaceutical ETF position peaked at $1.65M in Q2 2015.
  • 59 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2015.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q4 2015, filed 16 Feb 2016.